Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abd-Elsayed, 2015, KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia., Mol. Pain, 11, 10.1186/s12990-015-0048-8
Altaf, 2014, Incidence of cold-induced peripheral neuropathy and dose modification of adjuvant oxaliplatin-based chemotherapy for patients with colorectal cancer., Oncology, 87, 167, 10.1159/000362668
Amos, 1999, How Taxol stabilises microtubule structure., Chem. Biol., 6, R65, 10.1016/s1074-5521(99)89002-4
André, 2009, Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial., J. Clin. Oncol., 27, 3109, 10.1200/JCO.2008.20.6771
Arastu-Kapur, 2011, Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events., Clin. Cancer Res., 17, 2734, 10.1158/1078-0432.CCR-10-1950
Argyriou, 2012, Chemotherapy-induced peripheral neurotoxicity (CIPN): an update., Crit. Rev. Oncol. Hematol., 82, 51, 10.1016/j.critrevonc.2011.04.012
Argyriou, 2013, Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study., Cancer, 119, 3570, 10.1002/cncr.28234
Argyriou, 2014, Bortezomib-induced peripheral neurotoxicity: an update., Arch. Toxicol., 88, 1669, 10.1007/s00204-014-1316-5
Attal, 2009, Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study., Pain, 144, 245, 10.1016/j.pain.2009.03.024
Badros, 2007, Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature., Cancer, 110, 1042, 10.1002/cncr.22921
Balayssac, 2011, Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence., Expert Opin. Drug Saf., 10, 407, 10.1517/14740338.2011.543417
Baldwin, 2012, A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101., Am. Assoc. Cancer Res., 18, 5099, 10.1158/1078-0432.CCR-12-1590
Bao, 2016, Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk., Breast Cancer Res. Treat., 159, 327, 10.1007/s10549-016-3939-0
Barrière, 2012, Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization., Pain, 153, 553, 10.1016/j.pain.2011.11.019
Barzegar-Fallah, 2014, The neuroprotective effect of tropisetron on vincristine-induced neurotoxicity., Neurotoxicology, 41, 1, 10.1016/j.neuro.2013.12.002
Beijers, 2014, Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy., J. Community Support. Oncol., 12, 401, 10.12788/jcso.0086
Beijers, 2014, A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration., Support. Care Cancer, 22, 1999, 10.1007/s00520-014-2242-z
Beijers, 2016, Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice., Support. Care Cancer, 24, 2411, 10.1007/s00520-015-3032-y
Boyette-Davis, 2013, Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine., Cancer Chemother. Pharmacol., 71, 619, 10.1007/s00280-012-2047-z
Broyl, 2010, Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial., Lancet Oncol., 11, 1057, 10.1016/S1470-2045(10)70206-0
Brydoy, 2009, Observational study of prevalence of long-term raynaud-like phenomena and neurological side effects in testicular cancer survivors., J. Natl. Cancer Inst., 101, 1682, 10.1093/jnci/djp413
Carozzi, 2010, Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies., Exp. Neurol., 226, 301, 10.1016/j.expneurol.2010.09.004
Carozzi, 2013, Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse., PLoS ONE, 8, 10.1371/journal.pone.0072995
Cata, 2007, Quantitative sensory findings in patients with bortezomib-induced pain., J. Pain, 8, 296, 10.1016/j.jpain.2006.09.014
Cavaletti, 2004, Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study., Neurology, 62, 2291, 10.1212/WNL.62.12.2291
Cavaletti, 2010, Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies., Leuk. Lymphoma, 51, 1178, 10.3109/10428194.2010.483303
Cavaletti, 2002, Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity., Eur. J. Cancer, 1990, 1832, 10.1016/S0959-8049(02)00229-0
Chaudhry, 2003, Toxic neuropathy in patients with pre-existing neuropathy., Neurology, 60, 337, 10.1212/01.WNL.0000043691.53710.53
Chaudhry, 2008, Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy., J. Peripher. Nerv. Syst., 13, 275, 10.1111/j.1529-8027.2008.00193.x
Chaudhry, 1994, Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies., Ann. Neurol., 35, 304, 10.1002/ana.410350310
Chew, 2013, Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients., Eur. J. Clin. Pharmacol., 70, 155, 10.1007/s00228-013-1596-3
Custodio, 2014, Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study., Ann. Oncol., 25, 398, 10.1093/annonc/mdt546
de Graan, 2013, CYP3A4∗22 genotype and systemic exposure affect paclitaxel-induced neurotoxicity., Clin. Cancer Res., 19, 3316, 10.1158/1078-0432.CCR-12-3786
De Iuliis, 2015, Taxane induced neuropathy in patients affected by breast cancer: literature review., Crit. Rev. Oncol. Hematol., 96, 34, 10.1016/j.critrevonc.2015.04.011
Descoeur, 2011, Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors., EMBO Mol. Med., 3, 266, 10.1002/emmm.201100134
Di Cesare Mannelli, 2012, Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin., J. Pain, 13, 276, 10.1016/j.jpain.2011.11.009
Di Cesare Mannelli, 2016, Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: possible aid in chemotherapy induced neuropathy., Free Radic. Biol. Med., 93, 67, 10.1016/j.freeradbiomed.2016.01.023
Dilruba, 2016, Platinum-based drugs: past, present and future., Cancer Chemother. Pharmacol., 77, 1103, 10.1007/s00280-016-2976-z
Dimopoulos, 2011, Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study., Eur. J. Haematol., 86, 23, 10.1111/j.1600-0609.2010.01533.x
Diouf, 2015, Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia., JAMA, 313, 815, 10.1001/jama.2015.0894
Dougherty, 2004, Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients., Pain, 109, 132, 10.1016/j.pain.2004.01.021
Doyle, 2012, Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain., J. Neurosci., 32, 6149, 10.1523/JNEUROSCI.6343-11.2012
Dzagnidze, 2007, Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy., J. Neurosci., 27, 9451, 10.1523/JNEUROSCI.0523-07.2007
Earl, 1998, Long-term neurotoxicity of chemotherapy in adolescents and young adults treated for bone and soft tissue sarcomas., Sarcoma, 2, 97, 10.1080/13577149878055
Eckhoff, 2015, Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors., Eur. J. Cancer, 51, 292, 10.1016/j.ejca.2014.11.024
Egbelakin, 2011, Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia., Pediatr. Blood Cancer, 56, 361, 10.1002/pbc.22845
Engelen, 2009, Long-term morbidity of adjuvant whole abdominal radiotherapy (WART) or chemotherapy for early stage ovarian cancer., Eur. J. Cancer, 45, 1193, 10.1016/j.ejca.2009.01.006
Fernyhough, 2005, Activation of nuclear factor-kappaB via endogenous tumor necrosis factor alpha regulates survival of axotomized adult sensory neurons., J. Neurosci., 25, 1682, 10.1523/JNEUROSCI.3127-04.2005
Frederiks, 2015, Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: a systematic review., Cancer Treat. Rev., 41, 935, 10.1016/j.ctrv.2015.10.010
Ganz, 2003, Why and how to study the fate of cancer survivors: observations from the clinic and the research laboratory., Eur. J. Cancer, 39, 2136, 10.1016/S0959-8049(03)00489-1
García-Sanz, 2016, Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array., Hematol. Oncol., 10.1002/hon.2337
Gauchan, 2009, Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice., Neurosci. Lett., 458, 93, 10.1016/j.neulet.2009.04.029
Giannini, 2003, Thalidomide-induced neuropathy: a ganglionopathy?, Neurology, 60, 877, 10.1212/01.WNL.0000049462.03800.B1
Gilardini, 2012, Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy., Neurotoxicology, 33, 1, 10.1016/j.neuro.2011.10.010
Gilchrist, 2017, Short-term recovery of chemotherapy-induced peripheral neuropathy after treatment for pediatric non-CNS cancer., Pediatr. Blood Cancer, 64, 180, 10.1002/pbc.26204
Glasmacher, 2006, A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma., Br. J. Haematol., 132, 584, 10.1111/j.1365-2141.2005.05914.x
Glendenning, 2010, Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer., Cancer, 116, 2322, 10.1002/cncr.24981
González Pérez, 2007, Vincristine-induced acute neurotoxicity versus Guillain-Barré syndrome: a diagnostic dilemma., Eur. J. Neurol., 14, 826, 10.1111/j.1468-1331.2007.01842.x
Gornstein, 2014, The paradox of paclitaxel neurotoxicity: mechanisms and unanswered questions., Neuropharmacology, 76(Pt A), 175, 10.1016/j.neuropharm.2013.08.016
Gracias, 2011, Vasodilatation in the rat dorsal hindpaw induced by activation of sensory neurons is reduced by paclitaxel., Neurotoxicology, 32, 140, 10.1016/j.neuro.2010.09.006
Graf, 1996, Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A., Cancer, 77, 1356, 10.1002/(SICI)1097-0142(19960401)77:71356::AID-CNCR203.0.CO;2-#
Gréen, 2009, Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer., Basic Clin. Pharmacol. Toxicol., 104, 130, 10.1111/j.1742-7843.2008.00351.x
Haim, 1994, Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas., Cancer, 73, 2515, 10.1002/1097-0142(19940515)73:102515::AID-CNCR28207310113.0.CO;2-G
Hall, 2014, Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/001)., Eur. J. Cancer, 50, 2375, 10.1016/j.ejca.2014.06.007
Hara, 2013, Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion., Pain, 154, 882, 10.1016/j.pain.2013.02.023
Hershman, 2014, Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline., J. Clin. Oncol., 32, 1941, 10.1200/JCO.2013.54.0914
Hershman, 2011, Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy., Breast Cancer Res. Treat., 125, 767, 10.1007/s10549-010-1278-0
Hertz, 2013, CYP2C8∗3 increases risk of neuropathy in breast cancer patients treated with paclitaxel., Ann. Oncol., 24, 1472, 10.1093/annonc/mdt018
Hirvonen, 1989, Vincristine treatment of acute lymphoblastic leukemia induces transient autonomic cardioneuropathy., Cancer, 64, 801, 10.1002/1097-0142(19890815)64:4801::AID-CNCR28206404063.0.CO;2-E
Ho, 2014, Presentation and management of docetaxel-related adverse effects in patients with breast cancer., Cancer Manag. Res., 6, 253, 10.2147/CMAR.S40601
Höke, 2014, Rodent models of chemotherapy-induced peripheral neuropathy., ILAR J., 54, 273, 10.1093/ilar/ilt053
Hong, 2014, The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients., Curr. Oncol., 21, 174, 10.3747/co.21.1984
Hornick, 2008, Live-cell analysis of mitotic spindle formation in taxol-treated cells., Cell Motil. Cytoskeleton, 65, 595, 10.1002/cm.20283
Ibáñez, 2012, p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity., Trends Neurosci., 35, 431, 10.1016/j.tins.2012.03.007
Ibi, 2010, Piccolo knockdown-induced impairments of spatial learning and long-term potentiation in the hippocampal CA1 region., Neurochem. Int., 56, 77, 10.1016/j.neuint.2009.09.004
Jaggi, 2012, Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy., Toxicology, 291, 1, 10.1016/j.tox.2011.10.019
Jain, 2014, Vincristine-induced neuropathy in childhood ALL (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics., J. Child Neurol., 29, 932, 10.1177/0883073813491829
Jamieson, 2003, Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity., Br. J. Cancer, 88, 1942, 10.1038/sj.bjc.6601012
Javle, 2010, Recent advances in gastrointestinal oncology–updates and insights from the 2009 annual meeting of the American society of clinical oncology., J. Hematol. Oncol., 3, 10.1186/1756-8722-3-11
Ji, 2013, Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model., PLoS ONE, 8, 10.1371/journal.pone.0060733
Jimenez-Andrade, 2006, Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat., Neurosci. Lett., 405, 62, 10.1016/j.neulet.2006.06.043
Jones, 2005, Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer., J. Clin. Oncol., 23, 5542, 10.1200/JCO.2005.02.027
Jongen, 2015, Chemotherapy-induced peripheral neuropathies in hematological malignancies., J. Neurooncol., 121, 229, 10.1007/s11060-014-1632-x
Jordan, 2007, How do microtubule-targeted drugs work? An overview., Curr. Cancer Drug Targets, 7, 730, 10.2174/156800907783220417
Jordan, 2004, Microtubules as a target for anticancer drugs., Nat. Rev. Cancer, 4, 253, 10.1038/nrc1317
Kerckhove, 2017, Clinical assessment of new antineuropathic strategies for chemotherapy-induced peripheral neuropathy: pain should not be the principal endpoint., Pain, 158, 180, 10.1097/j.pain.0000000000000743
Khrunin, 2010, Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients., Pharmacogenomics J., 10, 54, 10.1038/tpj.2009.45
Kim, 2010, Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma., Qual. Life Res., 19, 1097, 10.1007/s11136-010-9670-0
Kraff, 2015, Pharmacokinetically based dosing of weekly paclitaxel to reduce drug-related neurotoxicity based on a single sample strategy., Cancer Chemother. Pharmacol., 75, 975, 10.1007/s00280-015-2724-9
Kumamoto, 2013, Polymorphisms of GSTP1, ERCC2 and TS-3’UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients., Oncol. Lett., 6, 648, 10.3892/ol.2013.1467
Landowski, 2005, Mitochondrial-mediated disregulation of Ca2+ is a critical determinant of Velcade (PS-341/bortezomib) cytotoxicity in myeloma cell lines., Cancer Res., 65, 3828, 10.1158/0008-5472.CAN-04-3684
LaPointe, 2013, Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy., Neurotoxicology, 37, 231, 10.1016/j.neuro.2013.05.008
Lavoie Smith, 2015, Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia., J. Peripher. Nerv. Syst., 20, 37, 10.1111/jns.12114
Leach, 2016, Is it my cancer or am I just getting older?: impact of cancer on age-related health conditions of older cancer survivors., Cancer, 122, 1946, 10.1002/cncr.29914
Ledeboer, 2007, Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats., Brain. Behav. Immun., 21, 686, 10.1016/j.bbi.2006.10.012
Leskelä, 2011, Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity., Pharmacogenomics J., 11, 121, 10.1038/tpj.2010.13
Li, 2009, Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NFkappaB p65., Int. J. Hematol., 90, 513, 10.1007/s12185-009-0409-z
Li, 2015, The cancer chemotherapeutic paclitaxel increases human and rodent sensory neuron responses to TRPV1 by activation of TLR4., J. Neurosci., 35, 13487, 10.1523/JNEUROSCI.1956-15.2015
Li, 2014, Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy., J. Pain, 15, 712, 10.1016/j.jpain.2014.04.001
Liew, 2013, Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocol., Leuk. Res., 37, 1632, 10.1016/j.leukres.2013.09.018
Liu, 2014, Tubulin inhibitors: a patent review., Expert Opin. Ther. Pat., 24, 69, 10.1517/13543776.2014.859247
Lolignier, 2015, The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia., Cell Rep., 11, 1067, 10.1016/j.celrep.2015.04.027
Mateos, 2012, How to maintain patients on long-term therapy: understanding the profile and kinetics of adverse events., Leuk. Res., 36(Suppl. 1), S35, 10.1016/S0145-2126(12)70007-3
McWhinney, 2009, Platinum neurotoxicity pharmacogenetics., Mol. Cancer Ther., 8, 10, 10.1158/1535-7163.MCT-08-0840
Minarik, 2015, Subcutaneous bortezomib in multiple myeloma patients induces similar therapeutic response rates as intravenous application but it does not reduce the incidence of peripheral neuropathy., PLoS ONE, 10, 10.1371/journal.pone.0123866
Mohty, 2010, Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations., Haematologica, 95, 311, 10.3324/haematol.2009.012674
Mols, 2013, Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry., J. Clin. Oncol., 31, 2699, 10.1200/JCO.2013.49.1514
Morawska, 2015, Therapy-related peripheral neuropathy in multiple myeloma patients., Hematol. Oncol., 33, 113, 10.1002/hon.2149
Moreau, 2011a, Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma., Blood, 118, 5752, 10.1182/blood-2011-05-355081
Moreau, 2011b, Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study., Lancet Oncol., 12, 431, 10.1016/S1470-2045(11)70081-X
Moriyama, 2012, Adverse interactions between antifungal azoles and vincristine: review and analysis of cases., Mycoses, 55, 290, 10.1111/j.1439-0507.2011.02158.x
Moser, 2005, Late non-neoplastic events in patients with aggressive non-Hodgkin’s lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials., Clin. Lymphoma Myeloma, 6, 122, 10.3816/CLM.2005.n.038
Naumann, 2001, Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity., Br. J. Haematol., 115, 323, 10.1046/j.1365-2141.2001.03126.x
Ness, 2013, Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study., Arch. Phys. Med. Rehabil., 94, 1451, 10.1016/j.apmr.2013.03.009
Nishikawa, 2008, Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia., J. Pediatr. Hematol. Oncol., 30, 519, 10.1097/MPH.0b013e31816624a4
Oerlemans, 2014, Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry., Ann. Hematol., 93, 1705, 10.1007/s00277-014-2099-8
Orejana-García, 2003, Charcot-Marie-Tooth disease and vincristine., J. Am. Podiatr. Med. Assoc., 93, 229, 10.7547/87507315-93-3-229
Park, 2011, Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility., Oncologist, 16, 708, 10.1634/theoncologist.2010-0248
Peng, 2013, Association between GSTP1 Ile105Val polymorphism and oxaliplatin-induced neuropathy: a systematic review and meta-analysis., Cancer Chemother. Pharmacol., 72, 305, 10.1007/s00280-013-2194-x
Peters, 2007, Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells., Exp. Neurol., 203, 42, 10.1016/j.expneurol.2006.07.022
Pignata, 2006, Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study., BMC Cancer, 6, 10.1186/1471-2407-6-5
Pike, 2012, Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer., Chemother. Res. Pract., 2012, 10.1155/2012/913848
Plasmati, 2007, Neuropathy in multiple myeloma treated with thalidomide: a prospective study., Neurology, 69, 573, 10.1212/01.wnl.0000267271.18475.fe
Podratz, 2011, Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons., Neurobiol. Dis., 41, 661, 10.1016/j.nbd.2010.11.017
Poruchynsky, 2008, Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition., Cell Cycle, 7, 940, 10.4161/cc.7.7.5625
Postma, 1993, Long-term effects of vincristine on the peripheral nervous system., J. Neurooncol., 15, 23, 10.1007/BF01050259
Qin, 2012, Combination of taxanes, cisplatin and fluorouracil as induction chemotherapy for locally advanced head and neck cancer: a meta-analysis., PLoS ONE, 7, 10.1371/journal.pone.0051526
Quasthoff, 2002, Chemotherapy-induced peripheral neuropathy., J. Neurol., 249, 9, 10.1007/PL00007853
Ramchandren, 2009, Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia., J. Peripher. Nerv. Syst., 14, 184, 10.1111/j.1529-8027.2009.00230.x
Rampen, 2013, Bortezomib-induced polyneuropathy., Neth. J. Med., 71, 128
Reyes-Gibby, 2009, Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel., J. Pain, 10, 1146, 10.1016/j.jpain.2009.04.006
Richardson, 2002, Thalidomide in multiple myeloma., Biomed. Pharmacother., 56, 115, 10.1016/S0753-3322(02)00168-3
Richardson, 2003, A phase 2 study of bortezomib in relapsed, refractory myeloma., N. Engl. J. Med., 348, 2609, 10.1056/NEJMoa030288
Richardson, 2010, Complications of multiple myeloma therapy, part 1: risk reduction and management of peripheral neuropathy and asthenia., J. Natl. Compr. Cancer Netw., 8 (Suppl. 1), S4, 10.6004/jnccn.2010.0115
Richardson, 2005, Bortezomib or high-dose dexamethasone for relapsed multiple myeloma., N. Engl. J. Med., 352, 2487, 10.1056/NEJMoa043445
Richardson, 2009, Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline., Br. J. Haematol., 144, 895, 10.1111/j.1365-2141.2008.07573.x
Rowinsky, 1993, Neurotoxicity of Taxol., J. Natl. Cancer Inst. Monogr., 15, 107
Saloustros, 2008, Paclitaxel and docetaxel in the treatment of breast cancer., Expert Opin. Pharmacother., 9, 2603, 10.1517/14656566.9.15.2603
Schneider, 2015, Genome-wide association studies for taxane-induced peripheral neuropathy in ECOG-5103 and ECOG-1199., Clin. Cancer Res., 21, 5082, 10.1158/1078-0432.CCR-15-0586
Schneider, 2012, Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer., J. Clin. Oncol., 30, 3051, 10.1200/JCO.2011.39.8446
Sharawy, 2015, Evaluation of multi-neuroprotective effects of erythropoietin using cisplatin induced peripheral neurotoxicity model., Exp. Toxicol. Pathol., 67, 315, 10.1016/j.etp.2015.02.003
Shimozuma, 2012, Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial., Support. Care Cancer, 20, 3355, 10.1007/s00520-012-1492-x
Shinde, 2016, Can pregabalin prevent paclitaxel-associated neuropathy?–An ACCRU pilot trial., Support. Care Cancer, 24, 547, 10.1007/s00520-015-2807-5
Siau, 2006, Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy., Anesth. Analg., 102, 1485, 10.1213/01.ane.0000204318.35194.ed
Sissung, 2008, ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel., Clin. Cancer Res., 14, 4543, 10.1158/1078-0432.CCR-07-4230
Sissung, 2006, Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia., Eur. J. Cancer, 42, 2893, 10.1016/j.ejca.2006.06.017
Staff, 2013, Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons., Neurotoxicology, 39, 124, 10.1016/j.neuro.2013.09.001
Stefansson, 2016, Oxaliplatin added to fluoropyrimidine for adjuvant treatment of colorectal cancer is associated with long-term impairment of peripheral nerve sensory function and quality of life., Acta Oncol., 55, 1227, 10.1080/0284186X.2016.1197420
Strumberg, 2002, Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer., Ann. Oncol., 13, 229, 10.1093/annonc/mdf058
Suzuki, 2004, Bad news from the brain: descending 5-HT pathways that control spinal pain processing., Trends Pharmacol. Sci., 25, 613, 10.1016/j.tips.2004.10.002
Tacchetti, 2014, Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study., Am. J. Hematol., 89, 1085, 10.1002/ajh.23835
Tanabe, 2013, Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer., Int. J. Clin. Oncol., 18, 132, 10.1007/s10147-011-0352-x
Tari, 1986, Action of vinca alkaloides on calcium movements through mitochondrial membrane., Pharmacol. Res. Commun., 18, 519, 10.1016/0031-6989(86)90147-5
Tariman, 2008, Peripheral neuropathy associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board., Clin. J. Oncol. Nurs., 12, 29, 10.1188/08.CJON.S1.29-35
Terrazzino, 2015, Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis., J. Peripher. Nerv. Syst., 20, 15, 10.1111/jns.12110
Thibault, 2013, Structural and molecular alterations of primary afferent fibres in the spinal dorsal horn in vincristine-induced neuropathy in rat., J. Mol. Neurosci., 51, 880, 10.1007/s12031-013-0095-4
Thornton, 2008, Delayed emotional recovery after taxane-based chemotherapy., Cancer, 113, 638, 10.1002/cncr.23589
Tofthagen, 2010, Surviving chemotherapy for colon cancer and living with the consequences., J. Palliat. Med., 13, 1389, 10.1089/jpm.2010.0124
Tofthagen, 2013, Oxaliplatin-induced peripheral neuropathy’s effects on health-related quality of life of colorectal cancer survivors., Support. Care Cancer, 21, 3307, 10.1007/s00520-013-1905-5
Tomaszewski, 2007, Cisplatin modulates voltage gated channel currents of dorsal root ganglion neurons of rats., Neurotoxicology, 28, 49, 10.1016/j.neuro.2006.07.005
Tran, 2006, Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms., Clin. Pharmacol. Ther., 79, 570, 10.1016/j.clpt.2006.02.003
van Gerven, 1994, Paclitaxel (Taxol) induces cumulative mild neurotoxicity., Eur. J. Cancer, 30A, 1074, 10.1016/0959-8049(94)90459-6
Vatandoust, 2014, A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer., Support. Care Cancer, 22, 513, 10.1007/s00520-013-2004-3
Velasco, 2010, Neurological monitoring reduces the incidence of bortezomib-induced peripheral neuropathy in multiple myeloma patients., J. Peripher. Nerv. Syst., 15, 17, 10.1111/j.1529-8027.2010.00248.x
Ventzel, 2016, Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel., Pain, 157, 560, 10.1097/j.pain.0000000000000404
Verstappen, 2005, Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening., Neurology, 64, 1076, 10.1212/01.WNL.0000154642.45474.28
Vincenzi, 2013, Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV., Support. Care Cancer, 21, 1313, 10.1007/s00520-012-1667-5
Wang, 2008, Cyclosporine increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system., Am. J. Physiol. Regul. Integr. Comp. Physiol., 294, R811, 10.1152/ajpregu.00543.2007
Wani, 2014, Nature as a remarkable chemist: a personal story of the discovery and development of Taxol., Anticancer Drugs, 25, 482, 10.1097/CAD.0000000000000063
Watkins, 2005, Immune regulation of central nervous system functions: from sickness responses to pathological pain., J. Intern. Med., 257, 139, 10.1111/j.1365-2796.2004.01443.x
Xiao, 2012, Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin., Pain, 153, 704, 10.1016/j.pain.2011.12.011
Yamamoto, 2015, Transient receptor potential ankyrin 1 that is induced in dorsal root ganglion neurons contributes to acute cold hypersensitivity after oxaliplatin administration., Mol. Pain, 11, 10.1186/s12990-015-0072-8
Yang, 2014, Spinal changes of a newly isolated neuropeptide endomorphin-2 concomitant with vincristine-induced allodynia., PLoS ONE, 9, 10.1371/journal.pone.0089583
Yothers, 2011, Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses., J. Clin. Oncol., 29, 3768, 10.1200/JCO.2011.36.4539
Zedan, 2014, Oxaliplatin-induced neuropathy in colorectal cancer: many questions with few answers., Clin. Colorectal Cancer, 13, 73, 10.1016/j.clcc.2013.11.004
Zhang, 2014, Paclitaxel: new uses for an old drug., Drug Des. Devel. Ther., 8, 279, 10.2147/DDDT.S56801